Anticancer drugs work by targeting and killing cancer cells, but they can also have side effects on healthy cells. Holographic microscopy allows researchers to study the effects of anticancer drugs on individual cells, and to identify the cellular mechanisms that are involved in drug resistance. This information can help researchers to develop more effective and less toxic anticancer drugs.
In one recent study, holographic microscopy was used to study the effects of the anticancer drug paclitaxel on HeLa cells, a type of cervical cancer cell. The researchers found that paclitaxel caused the cells to undergo a series of morphological changes, including the formation of membrane blebs and the elongation of the cells. These changes were consistent with the known effects of paclitaxel on the cell cycle, and they suggest that holographic microscopy can be used to study the mechanisms of action of anticancer drugs at the cellular level.
Holographic microscopy is a powerful new tool for studying cellular response to anticancer drugs. This technique has the potential to revolutionize the way we study cancer and to develop new and more effective treatments for this devastating disease.
